Drug Shortage Report for TRANDATE
Report ID | 123906 |
Drug Identification Number | 02106280 |
Brand name | TRANDATE |
Common or Proper name | Trandate |
Company Name | PALADIN LABS INC. |
Market Status | MARKETED |
Active Ingredient(s) | LABETALOL HYDROCHLORIDE |
Strength(s) | 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 tabs |
ATC code | C07AG |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2020-09-14 |
Actual start date | 2020-09-11 |
Estimated end date | 2020-11-30 |
Actual end date | 2020-10-07 |
Shortage status | Resolved |
Updated date | 2020-11-05 |
Company comments | Product on allocation - Orders may not be shipped entirely |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-09-09 | English | Compare |
v2 | 2020-09-09 | French | Compare |
v3 | 2020-09-11 | English | Compare |
v4 | 2020-09-11 | French | Compare |
v5 | 2020-09-12 | English | Compare |
v6 | 2020-11-05 | English | Compare |
v7 | 2020-11-05 | French | Compare |
Showing 1 to 7 of 7